PBLS
Parabilis Medicines, Inc.Company Information
- Company Name
- Parabilis Medicines, Inc.
- CIK
- CIK0001657677
- Category
- <br>Emerging growth company
- Ticker: Exchange
- PBLS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PBLS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-22
- Last sale
- —
- Shares purchased (TTM)
- 21,757,565
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 98,171,185
- Shares outstanding
- 28,908,277
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 13.32%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|
Assets Current | |||||||
| Cash And Cash Equivalents At Carrying Value | 1,087 | ||||||
| Marketable Securities Current | 34 | ||||||
| Prepaid Expense And Other Assets Current | 5 | ||||||
| Assets Current | 1,125 | ||||||
| Property Plant And Equipment Net | 7 | ||||||
| Restricted Cash | 3 | ||||||
| Operating Lease Right Of Use Asset | 36 | ||||||
| Other Assets | 4 | ||||||
| Assets | 1,175 | ||||||
Liabilities Current | |||||||
| Accounts Payable Current | 19 | ||||||
| Accrued Liabilities Current | 20 | ||||||
| Operating Lease Liability Current | 8 | ||||||
| Deferred Revenue Current | 10 | ||||||
| Finance Lease Liability Current | 1 | ||||||
| Long Term Debt Current | 6 | ||||||
| Liabilities Current | 63 | ||||||
| Operating Lease Liability Noncurrent | 32 | ||||||
| Finance Lease Liability Noncurrent | 1 | ||||||
| Deferred Revenue Noncurrent | 31 | ||||||
| Other Liabilities | 0 | ||||||
| Liabilities | 128 | ||||||
| Preferred Stock Value | 0 | ||||||
| Common Stock Value | 0 | ||||||
| Additional Paid In Capital | 1,687 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | ||||||
| Retained Earnings Accumulated Deficit | -639 | ||||||
| Stockholders Equity | 1,048 | ||||||
| Liabilities And Stockholders Equity | 1,175 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | ||||||
| Preferred Stock Shares Outstanding | 0 | ||||||
| Preferred Stock Shares Issued | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | ||||||
| Common Stock Shares Authorized | 600 | ||||||
| Shares Outstanding | 122 | ||||||
| Common Stock Shares Issued | 122 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialParabilis Medicines, Inc. (PBLS) — SEC Financial Statements & Analysis
Parabilis Medicines, Inc. (PBLS) is a pharmaceutical preparations company, incorporated in DE. Parabilis Medicines, Inc. trades on Nasdaq as: PBLS. Parabilis Medicines, Inc. (PBLS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Parabilis Medicines, Inc. carries a market cap of $791.22M, a P/B ratio of 0.76x, and an enterprise value of $-291.19M. On the balance sheet, it maintains a current ratio of 17.91x, a quick ratio of 17.83x, working capital of $1.06B, a debt-to-equity ratio of 0.12x, a debt ratio of 0.11, and net debt of $-1.08B. Figures sourced from SEC EDGAR.
- Market Cap
- $791.22M
- P/B TTM
- 0.76x
- Debt To Equity
- 0.12x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Parabilis Medicines, Inc. in?
Parabilis Medicines, Inc. (PBLS) operates in the Pharmaceutical Preparations industry.
What exchange does PBLS trade on?
Parabilis Medicines, Inc. (PBLS) trades on the Nasdaq.
Where is Parabilis Medicines, Inc. incorporated?
Parabilis Medicines, Inc. is incorporated in DE.
When was Parabilis Medicines, Inc. (PBLS)'s most recent SEC filing?
Parabilis Medicines, Inc. (PBLS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is PBLS's market cap?
Parabilis Medicines, Inc. (PBLS) has a market capitalization of $791.22M as of 2026-06-30.